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Abstract
Background: Diabetes mellitus deeply changes the genes expression of integrin (Itg)
subunits in several cells and tissues such as monocytes, arterial endothelium, kidney
glomerular cells, retina. Furthermore, hyperglycemia could impress and reduce the rate
of successful assisted as well as non-assisted pregnancy. Endometrium undergoes
thorough changes in normal menstrual cycle and the question is: What happens in
the endometrium under diabetic condition?
Objective: The aim of the current study was to investigate the endometrial gene
expression of α3, α4, αv, Itg β1 and β3 subunits in diabetic rat models at the time
of embryo implantation.
Materials andMethods: Twenty-eight rats were randomly divided into 4 groups: control
group, diabetic group, pioglitazone-treated group, and metformin-treated group. Real-
time PCR was performed to determine changes in the expression of Itg α3, α4, αv, β1,
and β3 genes in rat’s endometrium.
Results: The expression of all Itg subunits increased significantly in diabetic rats’
endometrium compared with control group. Treatment with pioglitazone significantly
reduced the level of Itg subunits gene expression compared with diabetic rats. While
metformin had a different effect on α3 and α4 and elevated these two subunits gene
expression.
Conclusion: Diabetes mellitus significantly increased the expression of studied Itg
subunits, therefore untreated diabetes could be potentially assumed as one of the
preliminary elements in embryo implantation failure.
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1. Introduction
Diabetes mellitus (DM) is referred to a member
of metabolic disorders whose common feature is
high blood glucose level. Diabetic individuals are
at more life-threatening risk than normoglycemic
people which can lead to increase in their health-
care costs and reduce their quality of life (1). The
dramatic increase in the number of people with
diabetes is due to population aging, changes in
lifestyle, obesity, and population growth (2). Type 2
diabetes mellitus (T2DM) or noninsulin-dependent
diabetes mellitus (NIDDM) is diagnosed in about
90% of cases before age 30. It ought to be consid-
ered, this age is approximately in the middle range
of women’s fertility age (2). Platt and colleagues
have reported that the rate of abortion after the
implantation of blastocyst in diabetic women is nine
times more than non-diabetic and healthy women
(3).
The World Health Organization has reported that
8–10% of couples in the world are suffering from
infertility, which is considered as a medical problem
(2). The specific mechanisms of the preliminary
causes of pregnancy failure, spontaneous and
frequent abortions in diabetic women have not yet
been clearly identified (4).
Unexplained infertility has several potential
causes, one of which may be embryo implanta-
tion failure (5). It seems that these events could
probably be in relation to underlying metabolic
disorders such as DM (6). In humans and animals,
the embryo implantation and the onset of preg-
nancy requires the occurrence of temporary and
extremely planned events which provide and equip
the endometrium at a specific time for blastocyst
acceptance. This specific time is termed as the
“window of implantation” (4, 7). During this period
of time, blastocyst binds to the maternal tissue
and adheres to endometrial epithelium, triggering
a cascade of complex events that ultimately leads
to the development of the placenta and embryo
(8).
Genes and proteins that are involved
in several uterine mechanisms, including
cytokines/chemokines, growth factors, enzymes,
aquaporins, and cell adhesion molecules such as
cadherins, selectins, and integrins (Itg), play roles
in regulating embryo-uterine dialogue at the time
of implantation (9).
Several Itg subunits including α3, α4, αv, β1,
and β3 have been identified in luminal and glan-
dular endometrial epithelium (5). α3β1 Itg has a
high tendency to bind with collagen, laminin, and
fibronectin in extracellular matrix. But α4β1 Itg is
known as a specific receptor for laminin, and the
αvβ3 Itg is a major fibronectin receptor (10, 11). Dia-
betes and subsequent increases in blood glucose
have been reported to affect the expression of Itg
(12). In diabetic nephropathy rat model, αv, β1, and
β3 Itg subunits gene expression was significantly
upregulated compared to the control group in the
renal cortex (13). In the early stage of diabetic
nephropathy in human, α3β1 Itg gene expression
significantly rose (14).
During a normal and natural menstrual cycle,
the Itg α4, αv, β1, and β3 subunits should be
periodically expressed in the endometrium at the
exact site and appropriate amount (15). In cases
with implantation failures, down regulation of αvβ3
expression were observed in endometrium (5, 16).
In mice and rabbits, blockage of Itg αv and β3
subunits could lead to reduction in the number of
implantation sites (17) and implantation failure could
occur at the time of endometrial penetration in β1
subunit null mice (18). As mentioned earlier, DM
could impress on Itg subunits gene expression in
different tissues and organs (12, 19).
Metformin is considered as the first line for
treatment in DM, if there is no contraindication
(20). Pioglitazone is one of the subsets of thiazo-
lidinedione (TZDs) family which is widely used for
the treatment of DM. This drug has attracted the
attention due to its multiple impressions beyond
controlling hyperglycemia in liver, muscle, and
adipose tissue by cell insulin-sensitizing activity
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and its effect on peroxisome proliferator-activated
receptor-gamma (PPARγ) (21).
The aim of the current study was to investigate
the endometrial gene expression of Itg α3, α4,
αv, β1, and β3 subunits in diabetic rat model at
the time of embryo implantation. We furthermore
assessed the effects of metformin and pioglitazone
treatment on the expression level of these Itg
subunits in the endometrium tissue of diabetic
rats.
2. Materials and Methods
2.1. Animals
This interventional experimental study was per-
formed on diabetic rat models at the central
laboratory of Isfahan University of Medical Sci-
ences in 2018. Adult virgin female Wistar rats
weighting 200 ± 25 gr, aged around six weeks
were purchased from the Pasteur Institute of
Iran. Animals were maintained in constant humid-
ity (40-70%), air-conditioned quarters (tempera-
ture 22-24°C) and 12 hr light/dark photoperiod
(22).
2.2. Study design and sampling
Twenty eight rats were randomly divided into
four groups with seven rats each as follows:
Control group, STZ + NA-induced diabetic group
without any treatment (FBS ≥ 250 mg/dl), dia-
betic group that received Pioglitazone 20 mg/kg/-
day by orogastric gavage, and diabetic rats that
received metformin 100 mg/kg/day by orogastric
gavage.
2.3. Induction of diabetes
In order to induce experimental T2DM in ani-
mals, Nicotinamide (NA, Sigma-Aldrich, Germany)
and Streptozotocin (STZ, Sigma-Aldrich, Germany)
were used. First, Nicotinamide (200-230 mg/kg)
and 15 min later, 60 mg/kg Streptozotocin were
intraperitoneally injected (23). After three days,
blood samples were taken to measure fasting
blood sugar (FBS) using a glucometer (HemoCue
Glucose 201+, Sweden). Animals with a blood
glucose level above 250 mg/dl were considered
as a diabetic model. Animals were maintained in
diabetic condition for four weeks. Then during
the next four weeks, they received hypoglycemic
drugs. FBS levels were measured every four
days using glucometer (HemoCue Glucose 201+,
Sweden) and glucose reagent strips (ACCU-CHEK
Active, Germany) through the dorsal vein of rats’
tail. Twenty four days after the administration of
metformin or pioglitazone, two female and one
male rats were placed in one cage in all study
groups in order to mate animals. The day after
that, the rats’ vagina was checked. The presence
of the vaginal plug revealed the first day of
pregnancy and the time of implantation window
was considered four days later (28th day after
the beginning of the treatment by both drugs).
Four weeks after the treatment with metformin
or pioglitazone, at the time of implantation, ani-
mals fasted overnight and were then sacrificed
by intraperitoneal injection of Ketamine hydrochlo-
ride (50 mg/kg) and Xylazine hydrochloride (7
mg/kg). Uterine horns were dissected and removed
in a sterile condition. Uteri were washed with
Hanks’ balanced salt solution and chopped in
several fragments. Tissues were then snap-frozen
and kept in -80°C until performing further experi-
ments.
2.4. Total RNA isolation and cDNA syn-
thesis
Total RNA was extracted from  endometrium
tissue using RNX-plus solution (Sinaclon, Iran) as
stated in manufacturer’s protocol. To determine
RNA integrity, 1% agarose gel electrophoresis was
used and total RNA concentrations were evaluated
by Nanodrop instrument (Nanolytik, Germany) at
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an optical density of 260 nm and stored at -80°C
for the next steps. Using DNase set (Fermentas,
Lithuania), DNase I treatment was performed in
order to eliminate genomic DNA in the RNA sam-
ples, Synthesis of cDNA was performed from 1 µg of
total RNA, by means of PrimeScriptTM RT reagent
Kit (TaKaRa, Japan) as stated in the protocol.
2.5. Quantitative real-time polymerase
chain reaction
The expression level of Itg α3, α4, αv, β1,
and β3 genes were assessed by quantitative
real-time reverse transcription-polymerase chain
reaction (RT-PCR). Specific primers (Table I) were
designed utilizing GeneRunner software, version
4.0 (Hastings Software, Inc.) and tested by BLAST
(Basic Local Alignment Search Tool (http://blast.
ncbi.nlm.nih.gov/Blast.cgi)) for specific attachment
to the genome. The β-actin gene was considered
as the housekeeping gene (24). Real-time PCR
was carried out with RealQ Plus ×2 Master Mix,
green (high ROX) (AMPLIQON, Denmark) on an
Applied Biosystems StepOnePlus𝑇𝑀 instrument.
Standard cycling steps were used to perform Real-
time PCR. Amplification conditions included of the
first denaturation at 95°C for 10 min, 40 cycles of
denaturation at 95°C for 15 sec, annealing at a
specific temperature for each gene, according to
Table I, for 60 sec, then an extension for 15 sec at
72°C.
Table I. Primer sequences used in the Real-time PCR technique







Itg α3-F 5´-AGCAGCCTCAGCAGATAATC-3´ 61.2
Itg α3-R 5´-GGAGGATATTGATGACAGGTC-3´ 59.8
56.8 176
Itg α4-F 5´-GCATACGAGTTTCAAGCAG-3´ 57.7
Itg α4-R 5´-CTCTGTGTTTCGTTTGGTG-3´ 57.4
54.4 142
Itg αv-F 5´-TGTCAAGGAGGATTCAGC-3´ 56.1
Itg αv -R 5´-AGTCCGTGTGGCTAGTTG-3´ 56.6
53.1 174
Itg β1-F 5´-TACTTCAGACTTCCGCATTG-3´ 61.3
Itg β1-R 5´-GCTGCTGACCAACAAGTTC-3´ 59.4
56.4 191
Itg β3 -F 5´-GTCGTCAGCCTTTACCAG-3´ 56.5
Itg β3- R 5´-GAGATCACGCACTTCCAG-3´ 56.3
53.3 164
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2.6. Ethical consideration
The Isfahan University of Medical Sciences Insti-
tutional Animal Ethical Committee approved all the
experimental procedures (IR.MUI.REC.1394.1.184).
2.7. Statistical analysis
In order to quantify the relative values of
gene expression, 2-ΔΔCT method (25) was used.
Statistical analysis was performed using Statistical
Package for the Social Sciences (SPSS) software,
version 16.0. All experiments were performed
at least twice or thrice and final results were
expressed as means ± standard deviation (SD).
One-Sample Kolmogorov–Smirnov Test was per-
formed in order to evaluate normality. One-way
ANOVA and Bonferroni post-test were performed
to detect statistical significance which was consid-
ered as p < 0.05.
3. Results
3.1. The gene expression of 𝛼3 integrin
The expression of Itg α3 was significantly
increased in diabetic group in comparison with
control group (p < 0.001, Figure 1). Following the
treatment by metformin, α3 gene expression was
significantly raised. A significant decrease was
observed after pioglitazone treatment compared
with the diabetic group (p < 0.001).
3.2. The gene expression of 𝛼4 inte-
grin
As Figure 2 shows, the Itg α4 gene expression
in the diabetic group was significantly higher than
in the control group (p < 0.001). The level of Itg
α4 gene expression in the pioglitazone-treated
group was lower than the diabetic group; however,
this difference was not significant (p = 1.00). On
the contrary, the level of Itg α4 gene expression
in metformin-treated group was higher than the
diabetic group, and a significant difference was
observed in comparison with the diabetic group (p
< 0.002).
3.3. The gene expression of 𝛼v integrin
As Figure 3 illustrates, the results of the expres-
sion of Itg αv gene show that the expression
in the diabetic group is higher than the other
groups and is statistically significant in comparison
with the control group (p < 0.001), metformin-
treated group (p < 0.001), and pioglitazone-treated
group (p < 0.001). Both the metformin and piogli-
tazone decreased the amount of αv gene expres-
sion compared with the diabetic group (p <
0.001).
3.4. The gene expression of 𝛽1 integrin
As Figure 4 reveals, the mean of Itg β1 gene
expression in diabetic group has significant differ-
ence in comparison with the control group (p <
0.001), metformin-treated group (p < 0.001), and
pioglitazone-treated group (p < 0.001). After the
treatment with both metformin and pioglitazone,
the level of Itg β1 gene expression significantly
decreased (p < 0.001).
3.5. The gene expression of 𝛽3 inte-
grin
Figure 5 demonstrates that its expression in
the diabetic group has significant difference with
the control group (p < 0.001) and significantly
decreased after the treatment with metformin (p =
0.001) and pioglitazone (p < 0.001).
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Figure 1. Comparison of Itg α3 gene expression at the time of embryo implantation in the rat endometrium.
All values were presented as mean ± SD; p < 0.05 was considered statistically significant; Diab + met = diabetic group treated
with metformin and Diab + Pi = diabetic group treated with piglitazone; * shows significant difference between diabetic group and
control group; # shows significant difference between diabetic group compared with Diab + met group and Diab + Pi group.
Figure 2. Comparison of Itg α4 gene expression at the time of embryo implantation in the rat endometrium.
All values were presented as mean ± SD; p < 0.05 was considered statistically significant; Diab + met = diabetic group treated
with metformin and Diab + Pi = diabetic group treated with piglitazone. * shows significant difference between diabetic group and
control group; # shows significant difference between diabetic group compared with Diab + met group and Diab + Pi group.
Figure 3. Comparison of Itg αv gene expression at the time of embryo implantation in the rat endometrium.
All values were presented as mean ± SD; p < 0.05 was considered statistically significant; Diab + met = diabetic group treated
with metformin and Diab + Pi = diabetic group treated with piglitazone. * shows significant difference between diabetic group and
control group. # shows significant difference between diabetic group compared with Diab + met group and Diab + Pi group.
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Figure 4. Comparison of Itg β1 gene expression at the time of embryo implantation in the rat endometrium.
All values were presented as mean ± SD; p < 0.05 was considered statistically significant; Diab + met = diabetic group treated
with metformin and Diab + Pi = diabetic group treated with piglitazone. * shows significant difference between diabetic group and
control group; # shows significant difference between diabetic group compared with Diab + met group and Diab + Pi group.
Figure 5. Comparison of Itg β3 gene expression at the time of embryo implantation in the rat endometrium.
All values were presented as mean ± SD; p < 0.05 was considered statistically significant; Diab + met = diabetic group treated
with metformin and Diab + Pi = diabetic group treated with piglitazone. * shows significant difference between diabetic group and
control group; # shows significant difference between diabetic group compared with Diab + met group and Diab + Pi group.
4. Discussion
DM is swiftly going to become one of the serious
health problems around the world affecting several
tissues and organs (2). The association of DM
with Itg subunits genes and proteins expression
changes has already been proven in various tis-
sues and organs such as kidney, retina, arterial
endothelium, and astrocytes (26, 27). The current
study revealed that the expression of Itg α3, α4,
αv, β1, and β3 subunits was significantly increased
in comparison with the control group in the diabetic
rat model.
Zhou and colleagues illustrated that Itg αv, β1,
and β3 subunits genes expression rose in renal
cortex of diabetic nephropathy rat model (13).
Similarly, Sawada and colleagues reported in the
early stage of human diabetic nephropathy, α3
and β1 genes expression increased (14). From our
point of view, effects of metabolic disorders such
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as DM probably highlight the reasons and causes
of unexplained infertility. In female reproductive
system, hormonal changes during the proliferative
phase and secretory phase leads to the presence
of Itg family molecules in different levels (5, 28).
For this reason, the exact time for evaluation of
gene expression in the endometrium has high
importance. Our study reveals that DM could affect
Itg genes expression at the time of implantation
window. It means the expression of Itg α3, α4,
αv, β1, and β3 subunits in diabetic rat models
has increased significantly in comparison with the
control group. Previously, the dysregulation of Itg
genes expression subunits has been accepted
as a reason for the reduction in conception rate
and receptivity of the endometrium. Also, it could
decrease the chance of embryo adhesion to the
endometrial epithelium (29). According to the lit-
erature, increasing blood glucose levels could
modulate the synthesis and function of Itg in
various tissues which by self can lead to the dis-
organized cell-to-cell- or cell-to-matrix adhesion.
These molecular disarrangements could change
the natural behavior of these tissues and cells
(30). Therefore, DM, as a metabolic disease, deeply
impress on the structural status of all of the tissues.
Due to the high expression of Itg subunits gene
in DM and the possibility of increased adhesion of
endometrial cells to each other and extracellular
matrix, it seems the invasion of the blastocyst
into endometrial epithelium could be reduced
and the implantation rate probably falls down
(24).
In this study, two common oral hypoglycemic
drugs, that is, metformin and pioglitazone were
administrated in diabetic rats. Our results reveal
that pioglitazone had a better effect on the reduc-
tion of all Itg subunit genes expression due to its
impression on genes expression pathway, which
previously rose in the diabetic group, while met-
formin reduced the level of αv, β1, and β3 gene
expression but elevated the values of α3 and
α4 subunit genes. From our point of view, these
different effects between two drugs are due to
their functional mechanisms. The family of TZDs
drug, such as pioglitazone, attaches to PPARγ.
Pioglitazone is a “highly selective” agonist for
PPARγ. The activation of this receptor activates
several DNA transcription factors that are involved
in several biological and metabolic pathways such
as differentiation, atherosclerosis, adipogenesis,
and insulin sensitivity (31). That is why, nowadays,
pioglitazone attract more attention and clinical
interest. These results indicate that pioglitazone (as
a member of the TZDs family) has a more effective
impression on controlling the expression of Itg
genes. Which may be due to interaction with PPARγ
(a key regulator of some genes expression) and
effect on DNA transcription in endometrial tissue
(24).
5. Conclusion
DM significantly increased the expression of
all the studied Itg subunits, therefore untreated
diabetes could be potentially considered as one of
the elements in embryo implantation failure. Our
study suggests that if no clinical contraindication
exists and after evaluation of the Itg proteins
expression, pioglitazone could be assumed as the
elective drug choice to control the upregulation of
endometrial Itg in diabetic rat models at the time of
implantation.
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